Literature DB >> 19032295

Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*.

C-J Huang1, H-F Liu, N-Y Su, Y-W Hsu, C-H Yang, C-C Chen, P-S Tsai.   

Abstract

This study examined the association between pressure pain sensitivity and various single nucleotide polymorphisms (SNPs) of human micro-, kappa-, and delta-opioid receptor (i.e. OPRM1, OPRK1, and OPRD1) genes in 72 healthy adult Taiwanese women of Han Chinese race. Pressure pain threshold and tolerance were measured by an algometer and polymorphisms of the opioid receptor genes determined from blood samples. Our data revealed that pressure pain threshold, but not tolerance, in subjects with the minor allele (termed 'GA') genotype of the IVS2+31G>A polymorphism of the OPRM1 gene was significantly higher than those with major allele (termed 'GG') genotype. Neither pressure pain threshold nor tolerance between major and minor alleles of other SNPs of the OPRM1, OPRK1, and OPRD1 genes were significantly different. These data suggest an association between the IVS2+31G>A SNP of the OPRM1 gene and pressure pain sensitivity in healthy adult females.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032295     DOI: 10.1111/j.1365-2044.2008.05760.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  16 in total

Review 1.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 2.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

3.  A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.

Authors:  Jin Xu; Zhigang Lu; Mingming Xu; Ling Pan; Yi Deng; Xiaohu Xie; Huifen Liu; Shixiong Ding; Yasmin L Hurd; Gavril W Pasternak; Robert J Klein; Luca Cartegni; Wenhua Zhou; Ying-Xian Pan
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

4.  Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.

Authors:  Jai Shankar K Yadlapalli; Navdeep Dogra; Anqi W Walbaum; William D Wessinger; Paul L Prather; Peter A Crooks; Maxim Dobretsov
Journal:  Anesth Analg       Date:  2017-09       Impact factor: 5.108

5.  Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438 A/G on Speed-Dating Success.

Authors:  Karen Wu; Chuansheng Chen; Robert K Moyzis; Ellen Greenberger; Zhaoxia Yu
Journal:  Hum Nat       Date:  2016-09

Review 6.  Recent advances in postoperative pain management.

Authors:  Nalini Vadivelu; Sukanya Mitra; Deepak Narayan
Journal:  Yale J Biol Med       Date:  2010-03

Review 7.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

8.  Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery.

Authors:  Wei Dong Wu; Yi Wang; Yong Ming Fang; Hai Yan Zhou
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Authors:  Elisa Mura; Stefano Govoni; Marco Racchi; Valeria Carossa; Guglielmina Nadia Ranzani; Massimo Allegri; Ron Hn van Schaik
Journal:  J Pain Res       Date:  2013-05-01       Impact factor: 3.133

10.  Gender, variation in opioid receptor genes and sensitivity to experimental pain.

Authors:  Hiroe Sato; Joanne Droney; Joy Ross; Anne Estrup Olesen; Camilla Staahl; Trine Andresen; Ruth Branford; Julia Riley; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Mol Pain       Date:  2013-04-09       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.